• 

  COVID-19 vaccine: Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune

  India | October 01, 2021 8:11 IST

  As many as nine centres have been identified across India for this phase, including Bharati Vidyapeeth Medical College Hospital.

• 

  Recruitment of volunteers for trial of Covid vaccine Covovax on children begins

  India | August 29, 2021 20:00 IST

  The trial would be held across 10 sites and would cover 920 children -- 460 each in the age groups of 12-17 and 2-11 -- according to official sources.

• 

  Time gap between both doses of Covishield may be reduced, say sources

  India | August 26, 2021 21:33 IST

  The government thinks that this move is feasible now because there are many vaccines available for the people, apart from Covishield and Covaxin, and also because there is a sufficient amount of vaccines available in the country.

• 

  SII chairman Cyrus Poonawalla says third dose desirable; warns against mix-and-match

  India | August 14, 2021 9:12 IST

  Cyrus Poonawalla on Friday strongly affirmed that mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged.

• 

  SII chairman Poonawalla against using cocktail of COVID-19 vaccines

  India | August 13, 2021 18:25 IST

  If cocktail vaccines are administered and if the result is not good, then SII may say that another vaccine was not good, vice versa, the other company might say that since you mixed Serum's vaccine, it did not give desired results, Poonawalla said.

• 

  Hopeful of launching Covovax for children in early 2022: Adar Poonawalla

  India | August 06, 2021 18:52 IST

  He also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishield production capacity to meet the demand.

• 

  SII signs pact with RDIF to manufacture Sputnik V, production to begin in September

  India | July 13, 2021 14:05 IST

  The RDIF and Serum Institute of India, the world’s largest vaccine producer, will start production of Sputnik V vaccine in September.

• 

  Serum Institute of India produces over 10 crore doses of Covishield in June

  India | June 27, 2021 18:31 IST

  According to information provided to the Drugs Controller General of India (DCGI) by the Pune-based Serum Institute of India, it has sent 45 batches of Covishield, amounting to 10. 80 crore doses, to the Central Drugs Laboratory, Kasauli for release in June so far 

• 

  WHO official says 'urgently trying to work with Indian govt, AstraZeneca, SII'

  World | June 19, 2021 10:24 IST

  “We are now urgently trying to work with AstraZeneca itself as well as SII, the Government of India to restart those shipments so that we can get those second doses into those populations because we are running” to a longer interval “than we would have liked,” a WHO official said.

• 

  Serum institute to start clinical trials of Novavax for children in July: Sources

  India | June 17, 2021 16:17 IST

  The US-based biotechnology company Novavax has tied up with the Serum Institute of India (SII) to manufacture its Covid-19 vaccine, namely Covovax.

• 

  Serum Institute of India gets DCGI nod to manufacture Sputnik V COVID-19 vaccine in India

  News | June 05, 2021 7:44 IST

  The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions.

Advertisement
• 

  Serum Institute gets nod to manufacture Russian Sputnik V vaccine in India

  India | June 05, 2021 0:06 IST

  Pune-based SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.

• 

  Pune airport handled domestic transportation of over 10 crore Covishield doses till May 27: AAI

  India | June 03, 2021 17:56 IST

  Pune Airport has been playing its role dedicatedly as the hub for the distribution of Serum Institute's Covidshield vaccine across India, the AAI's statement noted.

• 

  Serum Institute of India seeks DCGI nod to manufacture Sputnik V

  India | June 03, 2021 15:49 IST

  The Serum Institute has applied to the DGCI seeking permission to manufacture Sputnik V.

• 

  Serum Institute of India seeks indemnity against liabilities: Sources

  India | June 03, 2021 10:15 IST

  India has so far not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects.

• 

  Covishield single jab, mixing doses: Centre mulls tweaking Covid vaccination strategy

  India | June 01, 2021 16:01 IST

  Government could approve single-dose regimen for Covishield after a study to review the impact of its recent decision to extend the doses' interval.

• 

  Jeetega India | Vaccine production to increase manifold from July

  News | May 28, 2021 21:41 IST

  Both Serum Institute of India (SII) and Bharat Biotech would be ramping up production of Covid vaccines in India from July. SII is manufacturing Oxford-AstraZeneca vaccine called Covishield in India, while Bharat Biotech is producing Covaxin.

• 

  Global supply of COVAX hit due to coronavirus crisis in India, USAID tells lawmakers

  World | May 28, 2021 8:14 IST

  There are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.

• 

  No vaccination for 18+ age in Rajasthan today

  News | May 27, 2021 13:00 IST

  Rajasthan is currently facing shortage of vaccine. So the vaccination drive for 18+ age has currently been stopped in the state.

• 

  ICMR to examine effectiveness of AstraZeneca's SII-produced Covishield and Bharat Biotech's Covaxin

  India | May 26, 2021 21:49 IST

  Around 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.